Looking at corporate value through a portfolio lens provides an astute and reliable path to genuine value creation.
Sanjay K. Rao, PhD
Advertisement
Articles by Sanjay K. Rao, PhD
Recommendations for controlling spend.
On examination of the challenge and strategies, lack of adherence is in and of itself a preventable disease.
Advertisement
Latest Updated Articles
Value Creation Through Portfolio-Based Corporate StrategyPublished: April 5th 2023 | Updated:
Managing R&D RiskPublished: February 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
2
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
3
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
4
FDA Expands Indication for Merck’s Winrevair in Pulmonary Arterial Hypertension
5
